| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 633 |
| 1 | INFLIXIMAB | 155 |
| 2 | AZATHIOPRINE | 136 |
| 3 | PREDNISONE | 129 |
| 4 | VEDOLIZUMAB | 129 |
| 5 | METHOTREXATE SODIUM | 66 |
| 6 | USTEKINUMAB | 66 |
| 7 | MESALAMINE | 64 |
| 8 | METHOTREXATE | 59 |
| 9 | ADALIMUMAB-ADAZ | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 28 | 0.0081 |
| 1 | ENALAPRILAT | 1 | 0.0039 |
| 2 | METEX | 1 | 0.0026 |
| 3 | AZATHIOPRINE SODIUM | 6 | 0.0024 |
| 4 | ZIV-AFLIBERCEPT | 3 | 0.0023 |
| 5 | MESALAMINE | 64 | 0.0023 |
| 6 | TINIDAZOLE | 1 | 0.0023 |
| 7 | COLESTIPOL HYDROCHLORIDE | 6 | 0.0023 |
| 8 | OCTOCRYLENE, AVOBENZONE | 1 | 0.0022 |
| 9 | STREPTOMYCIN | 2 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 249 |
| 1 | Corticosteroid [EPC] | 236 |
| 2 | Integrin Receptor Antagonist [EPC] | 141 |
| 3 | Purine Antimetabolite [EPC] | 136 |
| 4 | Interleukin-23 Antagonist [EPC] | 100 |
| 5 | Aminosalicylate [EPC] | 82 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 80 |
| 7 | Interleukin-12 Antagonist [EPC] | 66 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 60 |
| 9 | Benzodiazepine [EPC] | 59 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 141 | 0.0016 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 3 | Purine Antimetabolite [EPC] | 136 | 0.0014 |
| 4 | Provitamin D2 Compound [EPC] | 40 | 0.0013 |
| 5 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 6 | GLP-2 Analog [EPC] | 14 | 0.0010 |
| 7 | Interleukin-23 Antagonist [EPC] | 100 | 0.0010 |
| 8 | Aminosalicylate [EPC] | 82 | 0.0008 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 5 | 0.0008 |